Chemotype Heterogeneity

Chemotype heterogeneity describes genetic variation within a strain or population that produces inconsistent cannabinoid and terpene profiles across individual plants, even when grown under identical conditions. This phenomenon occurs because cannabinoid synthesis pathways are polygenic—controlled by multiple genes—making expression unstable across generations or clones. Growers and breeders frequently encounter chemotype drift in open-pollinated or F1 hybrid populations, where some plants may express high CBD while siblings produce elevated THC, or terpene ratios diverge significantly. Understanding chemotype heterogeneity is essential for seed stability projects and clone selection protocols. Stabilized commercial strains typically result from backcrossing or selective breeding to reduce this variability and ensure predictable chemical output.

Breeders working to establish stable cultivars must identify and select for consistent chemotypes across generations, using lab testing to map cannabinoid inheritance patterns. Chemotype heterogeneity is often the first target for elimination when converting landrace or hybrid material into stable F1 or inbred lines.